Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

NCT00900172 · clinicaltrials.gov ↗

COMPLETED

Status

180

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: carboplatin
DRUG: paclitaxel
GENETIC: gene expression analysis
GENETIC: polymerase chain reaction
GENETIC: polymorphism analysis
OTHER: laboratory biomarker analysis

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]